A Secure System for Buying and Verifying the Authenticity of Drugs Using Blockchain Technology


  • K. Ravindran Assistant Professor, Department of Information Technology, Easwari Engineering College, Tamil Nadu, India
  • J. Pranav Niranjan Student, Department of Information Technology, Easwari Engineering College, Tamil Nadu, India
  • A. Sam Osborn Student, Department of Information Technology, Easwari Engineering College, Tamil Nadu, India




Drugs, Counterfeit, Blockchain, Pharmaceutical, Authenticity, Traceability


In the healthcare sector, ensuring the safety and legitimacy of drugs is a top priority. Counterfeit pharmaceuticals are a major problem for the industry, as they not only cause financial losses but also endanger public health and safety. These fake medications are hazardous or inefficient, putting lives at risk. The dissemination of fake medications has not been stopped by the use of conventional techniques for confirming drug legitimacy. This project presents a novel way to improve the security and authenticity of pharmaceutical purchases by utilizing blockchain technology. The key focus of this innovative project is to devise a blockchain-based secure system that will enable drug producers, distributors, and consumers to safely check the legitimacy of pharmaceuticals and track their provenance throughout the supply chain. The utilization of decentralized and immutable properties of blockchain technology makes it possible to create a transparent and impenetrable platform for documenting and confirming drug-related transactions. The blockchain will securely store every stage of the pharmaceutical supply chain, from production to retail, establishing a transparently traceable framework. Implementing a secure blockchain-based system for drug authentication helps effectively build trust within the pharmaceutical supply chain, protect consumers from counterfeit drugs, and make a positive impact on the overall improvement of public health. The transparency and security offered by blockchain technology in drug transactions have the potential to revolutionize the pharmaceutical industry, fostering a more reliable environment for drug procurement and distribution.


M. Pilkington, “Blockchain technology: principles and applications,” in Research Handbook on Digital Transformations, 2016, DOI: https://doi.org/10.4337/9781784717766.00019.

T. T. Dinh et al., “Untangling blockchain: A data processing view of blockchain systems,” in IEEE Transactions on Knowledge and Data Engineering, vol. 30, no. 7, pp. 1366-1385, 2018, DOI: https://doi.org/10.1109/tkde.2017.2781227.

A. A. Monrat, O. Schelen, and K. Andersson, “A survey of blockchain from the perspectives of applications, challenges, and opportunities,” in IEEE Access, vol. 7, pp. 117134-117151, 2019, DOI: https://doi.org/10.1109/access.2019.2936094.

T. Aste, P. Tasca, and T. Di Matteo, “Blockchain technologies: The foreseeable impact on society and industry,” in Computer, vol. 50, no. 9, pp. 18-28, 2017, DOI: https://doi.org/10.1109/mc.2017.357 1064.

C. Seife, “Research misconduct identified by the US Food and Drug Administration,” in JAMA Internal Medicine, vol. 175, no. 4, pp. 567, 2015, DOI: https://doi.org/10.1001/jamainternmed.2014.7774.

K. Toyoda et al., “A novel blockchain-based product ownership management system (POMS) for anti-counterfeits in the post supply chain,” in IEEE Access, vol. 5, pp. 17465-17477, 2017, DOI: https://doi.org/10.1109/access.2017.2720760.

D. Mao et al., “Credit evaluation system based on blockchain for multiple stakeholders in the food supply chain,” in International Journal of Environmental Research and Public Health, vol. 15, no. 8, pp. 1627, 2018, DOI: https://doi.org/10.3390/ijerph15081627.

F. Tian, “A supply chain traceability system for food safety based on HACCP, blockchain & Internet of things,” in 2017 International Conference on Service Systems and Service Management, 2017, DOI: https://doi.org/10.1109/icsssm.2017.7996119.

M. Benchoufi, R. Porcher, and P. Ravaud, “Blockchain protocols in clinical trials: Transparency and traceability of consent,” in F1000Research, vol. 6, pp. 66, 2018, DOI: https://doi.org/10.12688/ f1000research.10531.5.

R. K. Jha et al., “Counterfeit drug prevention in Pharma supply chain using blockchain technology,” in 2023 3rd International Conference on Intelligent Communication and Computational Techniques (ICCT), 2023, DOI: https://doi.org/10.1109/icct56969.2023.1007 6043.

T. S. et al., “Med secure: A blockchain based authenticated system for counterfeit medicine in Decentralized Peer to peer network,” in 2021 Asian Conference on Innovation in Technology (ASIANCON), 2021, DOI: https://doi.org/10.1109/asiancon51346.2021.9544648.

S. Raxit, J. Hossain Gourob, and H. Kabir, “A comprehensive drug management system by segregating spurious and substandard drugs using blockchain technology,” in 2021 International Conference on Automation, Control and Mechatronics for Industry 4.0 (ACMI), 2021, DOI: https://doi.org/10.1109/acmi53878.2021.9528238.

Y. Kostyuchenko and Q. Jiang, “Blockchain applications to combat the global trade of falsified drugs,” in 2020 International Conference on Data Mining Workshops (ICDMW), 2021, DOI: https://doi.org/10.1109/icdmw51313.2020.00127.




How to Cite

Ravindran, K., Pranav Niranjan, J., & Sam Osborn, A. (2023). A Secure System for Buying and Verifying the Authenticity of Drugs Using Blockchain Technology. Asian Journal of Science and Applied Technology, 12(2), 32–38. https://doi.org/10.51983/ajsat-2023.12.2.4047